140 related articles for article (PubMed ID: 14740870)
1. Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population.
Boutlis CS; Hobbs MR; Marsh RL; Misukonis MA; Tkachuk AN; Lagog M; Booth J; Granger DL; Bockarie MJ; Mgone CS; Levesque MC; Weinberg JB; Anstey NM
Am J Trop Med Hyg; 2003 Dec; 69(6):569-73. PubMed ID: 14740870
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide synthase 2(Lambaréné) (G-954C), increased nitric oxide production, and protection against malaria.
Kun JF; Mordmüller B; Perkins DJ; May J; Mercereau-Puijalon O; Alpers M; Weinberg JB; Kremsner PG
J Infect Dis; 2001 Aug; 184(3):330-6. PubMed ID: 11443559
[TBL] [Abstract][Full Text] [Related]
3. (CCTTT)n repeat polymorphism in the NOS2 gene promoter is associated with atopy.
Konno S; Hizawa N; Yamaguchi E; Jinushi E; Nishimura M
J Allergy Clin Immunol; 2001 Nov; 108(5):810-4. PubMed ID: 11692109
[TBL] [Abstract][Full Text] [Related]
4. iNOS promoter variants and severe malaria in Ghanaian children.
Cramer JP; Mockenhaupt FP; Ehrhardt S; Burkhardt J; Otchwemah RN; Dietz E; Gellert S; Bienzle U
Trop Med Int Health; 2004 Oct; 9(10):1074-80. PubMed ID: 15482399
[TBL] [Abstract][Full Text] [Related]
5. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma.
Kaise M; Miwa J; Suzuki N; Mishiro S; Ohta Y; Yamasaki T; Tajiri H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):139-45. PubMed ID: 17272999
[TBL] [Abstract][Full Text] [Related]
6. Significant association of longer forms of CCTTT Microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand.
Ohashi J; Naka I; Patarapotikul J; Hananantachai H; Looareesuwan S; Tokunaga K
J Infect Dis; 2002 Aug; 186(4):578-81. PubMed ID: 12195390
[TBL] [Abstract][Full Text] [Related]
7. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children.
Hobbs MR; Udhayakumar V; Levesque MC; Booth J; Roberts JM; Tkachuk AN; Pole A; Coon H; Kariuki S; Nahlen BL; Mwaikambo ED; Lal AL; Granger DL; Anstey NM; Weinberg JB
Lancet; 2002 Nov; 360(9344):1468-75. PubMed ID: 12433515
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent effect of plasma nitric oxide on parasite density in Ghanaian children with severe malaria.
Cramer JP; Nüssler AK; Ehrhardt S; Burkhardt J; Otchwemah RN; Zanger P; Dietz E; Gellert S; Bienzle U; Mockenhaupt FP
Trop Med Int Health; 2005 Jul; 10(7):672-80. PubMed ID: 15960706
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans.
Oates JC; Levesque MC; Hobbs MR; Smith EG; Molano ID; Page GP; Hill BS; Weinberg JB; Cooper GS; Gilkeson GS
J Rheumatol; 2003 Jan; 30(1):60-7. PubMed ID: 12508391
[TBL] [Abstract][Full Text] [Related]
10. NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity.
Kawaguchi Y; Tochimoto A; Hara M; Kawamoto M; Sugiura T; Katsumata Y; Okada J; Kondo H; Okubo M; Kamatani N
Arthritis Res Ther; 2006; 8(4):R104. PubMed ID: 16813666
[TBL] [Abstract][Full Text] [Related]
11. Genetic determinants of rheumatoid arthritis: the inducible nitric oxide synthase (NOS2) gene promoter polymorphism.
Pascual M; López-Nevot MA; Cáliz R; Koeleman BP; Balsa A; Pascual-Salcedo D; Martín J
Genes Immun; 2002 Aug; 3(5):299-301. PubMed ID: 12140750
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase 2 (NOS2) promoter polymorphisms in colorectal cancer.
Fransén K; Elander N; Söderkvist P
Cancer Lett; 2005 Jul; 225(1):99-103. PubMed ID: 15922861
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between NOS2 pentanucleotide repeat polymorphism and asthma phenotypes or exhaled nitric oxide concentration.
Leung TF; Liu EK; Li CY; Chan IH; Yung E; Lam CW; Wong GW
Pediatr Pulmonol; 2006 Jul; 41(7):649-55. PubMed ID: 16703578
[TBL] [Abstract][Full Text] [Related]
14. No evidence for linkage in the promoter region of the inducible nitric oxide synthase gene (NOS2) in a Danish type 1 diabetes population.
Johannesen J; Pociot F; Kristiansen OP; Karlsen AE; Nerup J;
Genes Immun; 2000 Aug; 1(6):362-6. PubMed ID: 11196682
[TBL] [Abstract][Full Text] [Related]
15. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain.
Gonzalez-Gay MA; Llorca J; Sanchez E; Lopez-Nevot MA; Amoli MM; Garcia-Porrua C; Ollier WE; Martin J
Rheumatology (Oxford); 2004 Sep; 43(9):1182-5. PubMed ID: 15226517
[TBL] [Abstract][Full Text] [Related]
16. Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes.
Levesque MC; Hobbs MR; O'Loughlin CW; Chancellor JA; Chen Y; Tkachuk AN; Booth J; Patch KB; Allgood S; Pole AR; Fernandez CA; Mwaikambo ED; Mutabingwa TK; Fried M; Sorensen B; Duffy PE; Granger DL; Anstey NM; Weinberg JB
Hum Genet; 2010 Feb; 127(2):163-82. PubMed ID: 19859740
[TBL] [Abstract][Full Text] [Related]
17. Question. Do NOS2 promoter polymorphisms protect against malaria?
Ascenzi P; Gradoni L; Visca P
IUBMB Life; 2004 Apr; 56(4):229-30. PubMed ID: 15230351
[No Abstract] [Full Text] [Related]
18. Increased risk of intestinal type of gastric adenocarcinoma in Japanese women associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoter.
Tatemichi M; Sawa T; Gilibert I; Tazawa H; Katoh T; Ohshima H
Cancer Lett; 2005 Jan; 217(2):197-202. PubMed ID: 15617837
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 and inducible nitric oxide synthase gene polymorphisms are associated with Type 2 diabetes.
Bagarolli RA; Saad MJ; Saad ST
J Diabetes Complications; 2010; 24(3):192-8. PubMed ID: 19395279
[TBL] [Abstract][Full Text] [Related]
20. Inducible nitric oxide synthase (iNOS) gene polymorphism and disease prevalence.
Qidwai T; Jamal F
Scand J Immunol; 2010 Nov; 72(5):375-87. PubMed ID: 21039732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
